Creative Biolabs-Immuno-oncology

Anti-CCR7 (clone R7J-0Z1G) SynExpress E1-Cy2-I17-P Modified CD8+ T cells (CAT#: ITS-1224-CR345)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCR7 (clone R7J-0Z1G). We employs the HBV (EF1α-Cy2-IL-17-PstI) vector components and the SynExpress system of the miRNA Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
mouse
Target
CCR7
Clone
R7J-0Z1G
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
EF1α
Effector Gene
IL-17
Insertion Sites
PstI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.86
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.